Lung cancer in patients with idiopathic pulmonary fibrosis: Clinical characteristics and impact on survival

J. S. Park, T. Lee, J. Y. Park, H. Y. Lee, H. J. Lim, Y. J. Cho, H. I. Yoon, J. H. Lee, S. Jheon, C. G. Yoo, C. T. Lee, S. K. Han (Seongnam, Seoul, Republic Of Korea)

Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Session: Diffuse pulmonary fibrosis
Session type: Thematic Poster Session
Number: 2328
Disease area: Interstitial lung diseases, Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. S. Park, T. Lee, J. Y. Park, H. Y. Lee, H. J. Lim, Y. J. Cho, H. I. Yoon, J. H. Lee, S. Jheon, C. G. Yoo, C. T. Lee, S. K. Han (Seongnam, Seoul, Republic Of Korea). Lung cancer in patients with idiopathic pulmonary fibrosis: Clinical characteristics and impact on survival. Eur Respir J 2013; 42: Suppl. 57, 2328

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pemetrexed in advanced non-small cell lung cancer patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Advances in the therapy of lung cancer
Year: 2013


Neoplasia in patients with ILD; shortened survival
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Clinical profile of idiopathic pulmonary fibrosis with lung cancer
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011


Is toll like receptor 4 a common pathway hypothesis for development of lung cancer and idiopathic pulmonary fibrosis?
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016


Incidence, outcomes and risk factors for neoplasms in explanted lungs
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016


Clinical effect of pirfenidone on incidence of lung carcinoma in chronic interstitial pneumonia
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014

Possible indication for surgical resection of lung cancer associated with combined pulmonary fibrosis and emphysema (CPFE)
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

Assessment of nutritional status in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016


Clinical impact of an interstitial lung disease Nurse on patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018



Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – ILDs 3
Year: 2014


Lung cancer as a comorbidity in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases
Year: 2012

Long-term survival analysis: Pirfenidone compared to standard care for the treatment of patients with idiopathic pulmonary fibrosis
Source: International Congress 2014 – Clinical trials in IPF
Year: 2014


Prognostic influence of comorbidities in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – ILDs 2
Year: 2014

Idiopathic pulmonary fibrosis: Gender differences in survival and functional decline. A retrospective study
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016


Prognostic affect of the chronic obstructive pulmonary disease on the local-advanced stage non-small cell lung cancer
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014

Inspiration plus: baseline characteristics of the canadian registry for IPF patients on pirfenidone
Source: International Congress 2016 – Orphan diseases II
Year: 2016

Comparison of physiological impairment in ILD patients with and without diagnostic IPF features
Source: International Congress 2014 – ILDs 4
Year: 2014


Efficacy of pirfenidone in idiopathic pulmonary fibrosis: A single center experience
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016


The effect of pirfenidone with patients with idiopathic pulmonary fibrosis in one university hospital
Source: International Congress 2014 – ILDs 4
Year: 2014


The impact of chronic obstructive pulmonary disease on survival of the patients with small-cell lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015